Monsanto/Bayer Review Likely to Go to Phase Two in India

The Competition Commission of India is likely to move the Monsanto/Bayer deal into Phase Two, sources following the situation believe. Anshuman Sakle, a competition partner at Cyril Amarchand Mangaldas, explained thatfeatured

BASF Likely Bids for Additional Assets Bayer May Need to Offer

Updated at 12:30pm EDT – With additional reporting by Valeria Camerino – While the European Commission evaluates Bayer’s acquisition of Monsanto in the wake of Bayer’s announcement of a sale of €5.9 billion of businesses to BASF, sources close to the situation told CTFN that iffeatured

Bayer Agreement with BASF Does Not Answer All EC Antitrust Issues

Last week BASF agreed to acquire significant parts of Bayer’s seed and non-selective herbicide businesses for $7 billion, but the deal does not answer all offeatured

Monsanto/Bayer Early Remedy Package Not Expected at European Commission

As the European Commission’s review of Bayer’s acquisition of Monsanto proceeds, Bayer is not planning to proactively offer remedies to the commission beyond thosefeatured

Monsanto and Bayer in Remedy Discussions with Indian Regulator

Monsanto and Bayer are in pre-phase 2 remedy negotiations with the Competition Commission of India, several antitrust sources familiarfeatured

R&D Concerns Secondary in Monsanto/Bayer Deal

Bayer’s recent announcement that the completion of its $66 billion takeover of Monsanto will stretch into 2018 was not surprising given the deal’s complexity To Keep Reading, Request a Trial Already a subscriber? Log-infeatured

360b / Shutterstock.com

Rivals Call for Conditional Approval of Dow/DuPont in Brazil

German chemical company BASF has asked Brazilian regulator CADE to impose remedies on the planned merger between US peers Dow and DuPont, CTFN has learned. In a regulatory filing published on Februaryfeatured

360b / Shutterstock.com

Brazil Fears Agrochemical Deals May Lead to Price Increases

Brazil’s Ministry of Agriculture, Livestock, and Supply (MAPA) is concerned that the planned agrochemical mergers will raise prices for farmers, an antitrust lawyer involved in CADE’s review of such deals told CTFN. Although “more market share does not necessarily mean higher prices for farmers,” the lawyer pointed out that, Dow-DuPont,featured

Monsanto/Bayer Merger to Face Opposition in Africa

Bayer’s $66 billion bid for genetically modified seed and herbicide producer Monsanto faces strong opposition from a range of stakeholders in South Africa and neighboring countries, sources told CTFN. “Food security is a key issue in this part of the world,” Chris Charter, director and national head of Competition at South Africanfeatured

360b / Shutterstock.com

Dow/DuPont Seen Clearing DOJ

The Dow/DuPont merger, which has been under antitrust scrutiny for almost eight months, is expected to gain clearance from the Department of Justice, even as the newly announced Bayer/Monsanto and the Agrium/Potash deals raise the heat on big agricultural combinations, two well-placed sources in the industry told CTFN. “The added question from the EU are … Read Morefeatured

ricochet64 / Shutterstock.com
X

Interested in a trial?

Simply fill out the form below and one of our representatives will be in touch.